HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3

Journal of Experimental Medicine

Volumn 188, Issue 3, 1998, Pages 609-614

  Hadida, Fabienne ^a   Vieillard, Vincent ^b   Autran, Brigitte ^a   Clark Lewis, Ian ^c   Baggiolini, Marco ^d   Debré, Patrice ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT CURIE   (France)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

CD8+ T lymphocytes; Eotaxin; Monocyte chemotactic protein 3; Monocyte chemotactic protein 4; RANTES antagonist

Indexed keywords

EOTAXIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; RANTES;

ANTIVIRAL ACTIVITY; ARTICLE; CELL MEDIATED CYTOTOXICITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PRIORITY JOURNAL;

CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; HIV INFECTIONS; HIV-1; HUMANS; RANTES; RECEPTORS, CHEMOKINE;

EID: 0032479921     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.3.609     Document Type: Article

References (38)

1. Autran, B., F. Hadida, and G. Haas. 1996. Evolution and plasticity of CTL responses against HIV. Curr. Opin. Immunol. 8:546-553.
2. Gotch, F.M., D.F. Nixon, N. Alp, A.J. McMichael, and L.K. Borysievicz. 1990. High frequency of memory and effector Gag-specific cytotoxic T lymphocytes in HIV seropositive individuals. Int. Immunol. 2:707-712.
3. Hoffenbach, A., P. Langlade-Demoyen, E. Vilmer, G. Dadaglio, F. Michel, C. Mayaud, B. Autran, and F. Plata. 1989. Very high frequencies of HIV specific cytotoxic T lymphocytes in humans. J. Immunol. 142:452-456.
4. Hadida, F., A. Parrot, M.P. Kieny, B. Sadat-Sowti, C. Mayaud, P. Debré, and B. Autran. 1992. Carboxyl-terminal and central regions of human immunodeficiency virus-1 Nef recognized by cytotoxic T lymphocytes from lymphoid organs. J. Clin. Invest. 89:53-60.
5. Joly, P., J.M. Guillon, C. Mayaud, F. Plata, I. Theodorou, M. Denis, P. Debré, and B. Autran. 1989. Cell mediated suppression of HIV-specific cytotoxic T lymphocytes. J. Immunol. 143:2193-2201.
6. Rivière, Y., M.B. McChesney, F. Porrot, F. Tanneau-Salvadori, P. Sansonetti, O. Lopez, G. Pialoux, V. Feuillie, M. Mollereau, S. Chamaret, et al. 1995. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retroviruses. 11:903-907.
7. + T cells. Science. 270:1811-1815.
8. Samson, M., F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.M. Farber, S. Saragosti, C. Lapouméroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:722-725.
9. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675-705.
10. D'Souza, M.P., and V.A. Harden. 1996. Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research. Nat. Med. 2:1293-1300.
11. Nixon, D.F., A.R.M. Townsend, J.G. Elvin, C.R. Rizza, J. Gallwey, and A.J. McMichael. 1988. HIV-1 Gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature. 336:484-487.
12. Hadida, F., G. Haas, N. Zimmermann, A. Hosmalin, R. Spohn, R. Jung, P. Debré, and B. Autran. 1995. Cytotoxic T lymphocytes from lymphoid organs recognize an optimal HLA-A2 and -B52 restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 Nef. J. Immunol. 154:4174-4186.
13. + positive cytotoxic lymphocytes in acquired immunodeficiency syndrome lymphomas. Hum. Pathol. 26:284-290.
14. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 234:1563-1565.
15. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl. Acad. Sci. USA. 88:11276-11280.
16. Salter, R.D., C. Clayberger, C.E. Lomen, A.M. Krensky, and P. Parham. 1982. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule. Eur. J. Immunol. 166:283-290.
17. - T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency. Int. Immunol. 6:1739-1749.
18. Clark-Lewis, I., B. Moser, A. Walz, M. Baggiolini, G.J. Scott, and R. Aebersold. 1991. Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide 2. Biochemistry. 30:3128-3135.
19. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur. J. Immunol. 25:64-68.
20. Gong, J.-H., M. Uguccioni, B. Dewald, M. Baggiolini, and I. Clark-Lewis. 1996. RANTES and MCP-3 antagonists bind multiple chemokine receptors. J. Biol. Chem. 271:10521-10527.
21. Rot, A., M. Krieger, T. Brunner, S.C. Bischoff, T.J. Schall, and C.A. Dahinden. 1992. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176:1489-1495.
22. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin-8 and RANTES. Eur. J. Immunol. 25:751-756.
23. Bazan, J.F., and T.J. Schall. 1996. Interleukin-16 or not. Nature. 381:29-30.
24. Proudfoot, A.E.I., C.A. Power, A. Hoogewerf, M.O. Montjovent, F. Borlat, and T.N.C. Wells. 1995. Characterization of the RANTES/MIP-1α receptor (CC CKR-1) stably transfected in HEK 293 cells and the recombinant ligands. FEBS Lett. 376:19-23.
25. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569-577.
26. Heath, H., S.X. Qin, P. Rao, L.J. Wu, G. LaRosa, N. Kassam, P.D. Ponath, and C.R. Mackay. 1997. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:178-184.
27. Yamada, H., K. Hirai, M. Miyamasu, M. Iikura, Y. Misaki, S. Shoji, T. Takaishi, T. Kasahara, Y. Morita, and K. Ito. 1997. Eotaxin is a potent chemotaxin for human basophils. Biochem. Biophys. Res. Commun. 231:365-368.
28. Samson, M., O. Labbe, C. Mollereau, G. Vassart, and M. Parmentier. 1996. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry. 35:3362-3367.
29. Power, C.A., A. Meyer, K. Nemeth, K.B. Bacon, A.J. Hoogewerf, A.E.I. Proudfoot, and T.N.C. Wells. 1995. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J. Biol. Chem. 270:19495-19500.
30. Imai, T., M. Baba, M. Nishimura, M. Kakizaki, S. Takagi, and O. Yoshie. 1997. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 272:15036-15042.
31. Cao, J.X., P.D. Gershon, and D.N. Black. 1995. Sequence-analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. Virology. 209:207-212.
32. + cells in HIV infection produce macrophage inflammatory protein-1α and RANTES: a comparative study in long term survivors and progressor patients. Immunol. Lett. 53:105-108.
33. + cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:3120-3128.
34. Scala, E., G. D'Offizi, R. Rosso, O. Turriziani, R. Ferrara, A.M. Mazzone, G. Antonelli, F. Aiuti, and R. Paganelli. 1997. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J. Immunol. 158:4485-1492.
35. Price, D.A., A.K. Sewell, T. Dong, R. Tan, J.R. Goulder, S.L. Rowland-Jones, and R.E. Phillips. 1998. Antigen-specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr. Biol. 8:355-358.
36. Sallusto, F., C.R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:2005-2007.
37. Taub, D.D., S.M. Turcovski-Corrales, M.L. Key, D.L. Longo, and W.J. Murphy. 1996. Chemokines and T lymphocyte activation: I. β chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:2095-2103.
38. Taub, D.D., J.R. Ortaldo, S.M. Turcovski-Corrales, M.L. Key, D.L. Longo, and W.J. Murphy. 1996. β chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J. Leukocyte Biol. 59:81-89.